142 related articles for article (PubMed ID: 7539239)
1. Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis.
Jaskiewicz K; Chasen MR
Anticancer Res; 1995; 15(2):559-62. PubMed ID: 7539239
[TBL] [Abstract][Full Text] [Related]
2. Integrins as differential cell lineage markers of primary liver tumors.
Volpes R; van den Oord JJ; Desmet VJ
Am J Pathol; 1993 May; 142(5):1483-92. PubMed ID: 7684197
[TBL] [Abstract][Full Text] [Related]
3. Integrin expression on normal and neoplastic human breast epithelium.
Damjanovich L; Fülöp B; Adány R; Nemes Z
Acta Chir Hung; 1997; 36(1-4):69-71. PubMed ID: 9408292
[TBL] [Abstract][Full Text] [Related]
4. Laminin alpha 5 mediates ectopic adhesion of hepatocellular carcinoma through integrins and/or Lutheran/basal cell adhesion molecule.
Kikkawa Y; Sudo R; Kon J; Mizuguchi T; Nomizu M; Hirata K; Mitaka T
Exp Cell Res; 2008 Aug; 314(14):2579-90. PubMed ID: 18635166
[TBL] [Abstract][Full Text] [Related]
5. [Expression of the integrin alpha 5 subunit in hepatocellular carcinoma].
Yao M; Zhou X; Zha X
Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):382-4. PubMed ID: 9772498
[TBL] [Abstract][Full Text] [Related]
6. Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study.
Nejjari M; Hafdi Z; Gouysse G; Fiorentino M; Béatrix O; Dumortier J; Pourreyron C; Barozzi C; D'errico A; Grigioni WF; Scoazec JY
Hepatology; 2002 Aug; 36(2):418-26. PubMed ID: 12143051
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
Ruck P; Xiao JC; Kaiserling E
Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
[TBL] [Abstract][Full Text] [Related]
9. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
10. Cell-to-cell contact modulates the expression of the beta 1 family of integrins in primary cultures of thyroid cells.
Vitale M; Casamassima A; Illario M; Bassi V; Fenzi G; Rossi G
Exp Cell Res; 1995 Sep; 220(1):124-9. PubMed ID: 7545127
[TBL] [Abstract][Full Text] [Related]
11. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
12. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell-matrix adhesion molecules in the liver and their modulation during fibrosis.
Scoazec JY
J Hepatol; 1995; 22(2 Suppl):20-7. PubMed ID: 7545194
[No Abstract] [Full Text] [Related]
14. Patterns of integrin common chain beta 1 and collagen IV immunoreactivity in hepatocellular carcinoma. Correlations with tumour growth rate, grade and size.
Patriarca C; Roncalli M; Gambacorta M; Cominotti M; Coggi G; Viale G
J Pathol; 1993 Sep; 171(1):5-11. PubMed ID: 7693901
[TBL] [Abstract][Full Text] [Related]
15. Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells.
Masumoto A; Arao S; Otsuki M
Hepatology; 1999 Jan; 29(1):68-74. PubMed ID: 9862852
[TBL] [Abstract][Full Text] [Related]
16. Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: differential regulation of alpha2, alpha3 and beta1.
Judware R; Culp LA
Oncogene; 1997 Mar; 14(11):1341-50. PubMed ID: 9178894
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria.
Aucejo F; Kim R; Zein N; Quintini C; Uso TD; Lopez R; Eghtesad B; Fung J; Miller C; Yerian L
Liver Transpl; 2009 Feb; 15(2):169-76. PubMed ID: 19177438
[TBL] [Abstract][Full Text] [Related]
18. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
[TBL] [Abstract][Full Text] [Related]
20. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]